Clinical Trial

Validation and Usability Study of the SleepView+ Home Sleep Testing System for the Evaluation of Moderate to Severe Obstructive Sleep Apnea.

Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated March 17, 2026 (before its estimated August 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this observational study is to characterize the performance of the SleepView+ home sleep test system for the evaluation of moderate to severe obstructuve sleep apnea (OSA) in adult and pediatric patients (ages 12 and over). This study is being conducted in patients being evaluated for a sleep disorder who are scheduled to undergo an in lab polysomnigraphic study (PSG), enriching for suspected obstructive sleep apnea. This study will involve two phases: A - comparison of SleepView+ detection of apneas and hypopneas to simultaneously collected in lab PSG (validation phase) and B - evaluation of the ability of patients to use the SleepView+ system in their home environment without sleep technologist support (usability phase) Participants will progress from phase A to phase B.
Trial Details
NCT Number NCT07476313
Lead Sponsor Beacon Biosignals
Conditions Obstructive Sleep Apnea
Enrollment 200 participants
Start Date 2026-02-15
Primary Completion 2026-08-15 (estimated)
Study Completion 2026-12-15 (estimated)
Updated on ClinicalTrials.gov 2026-03-17